3,732
Views
1
CrossRef citations to date
0
Altmetric
Review

Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias

ORCID Icon & ORCID Icon
Pages 515-524 | Received 04 Jan 2023, Accepted 18 May 2023, Published online: 23 May 2023

References

  • Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone; 2004.
  • Berentsen S, Barcellini W, Longo DL. Autoimmune Hemolytic Anemias. N Engl J Med. 2021 Oct 7;385(15):1407–1419. DOI:10.1056/NEJMra2033982
  • Barcellini W, Zaninoni A, Giannotta JA, et al. New insights in autoimmune hemolytic anemia: from pathogenesis to therapy stage 1. J Clin Med. 2020;9(12):3859. DOI:10.3390/jcm9123859
  • Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting. Blood Rev. 2020;41:100648.
  • Shulman IA, Branch DR, Nelson JM, et al. Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA. 1985;253(12):1746–1748. DOI:10.1001/jama.1985.03350360072021
  • Sokol RJ, Booker DJ, Stamps R, et al. Direct coombs test-negative autoimmune hemolytic anemia and low-affinity IgG class antibodies. Immunohematology. 1997;13(4):115–118. DOI:10.21307/immunohematology-2019-725
  • Barcellini W, Giannotta J, Fattizzo B. Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev Hematol. 2020;13(6):585–597.
  • Feuille EJ, Anooshiravani N, Sullivan KE, et al. Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry. J Clin Immunol. 2018;38(1):28–34. DOI:10.1007/s10875-017-0456-9
  • Motta I, Giannotta J, Ferraresi M, et al. Autoimmune hemolytic anemia as a complication of congenital anemias. a case series and review of the literature. J Clin Med. 2021;10(15):3439. DOI:10.3390/jcm10153439
  • Gormezano NW, Kern D, Pereira OL, et al. Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients. Lupus. 2017;26(4):426–430. DOI:10.1177/0961203316676379
  • Nenova IS, Valcheva MY, Beleva EA, et al. Autoimmune phenomena in patients with solid tumors. Folia Med (Plovdiv). 2016;58(3):195–199. DOI:10.1515/folmed-2016-0026
  • Barcellini W, Giannotta JA, Fattizzo B. Autoimmune complications in hematologic neoplasms. Cancers (Basel). 2021;13(7):1532.
  • Stein B, DeCredico N, Hillman L. Evaluation of the Direct Antiglobulin Test (DAT) in the setting of mycoplasma pneumoniae Infection. JAMA. 2018;319(13):1377–1378.
  • Tanios GE, Doley PB, Munker R. Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the food and drug administration database and review. Eur J Haematol. 2019;102(2):157–162.
  • Azizi G, Tavakol M, Rafiemanesh H, et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017;13(11):1099–1106. DOI:10.1080/1744666X.2017.1384312
  • Fattizzo B, Barcellini W. Autoimmune hemolytic anemia: causes and consequences. Expert Rev Clin Immunol. 2022 Jul;18(7):731–745.
  • Coombs RR, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol. 1945;26:255–266.
  • LE S, Cunningham MJ. Autoimmune hemolytic anemias. In: Hillyer C, LE S, Ness P, Anderson K Roback J, editors. Blood banking and transfusion medicine: basic principles and practice. 2nd ed. Philadelphia: Churchill Livingstone; 2007. p. 557–570.
  • Roback JD, Combs MR, Grossman BJ, et al. AABB Technical Manual. 16th ed. Bethesda: AABB; 2008.
  • Barcellini W. Pitfalls in the diagnosis of autoimmune haemolytic anaemia. Blood Transfus. 2015;13(1):3–5.
  • Parker V, Tormey CA. The direct antiglobulin test: indications, interpretation, and pitfalls. Arch Pathol Lab Med. 2017;141(2):305–310.
  • Dubarry M, Charron C, Habibi B, et al. Quantitation of immunoglobulin classes and subclasses of autoantibodies bound to red cells in patients with and without hemolysis. Transfusion. 1993;33(6):466–471.
  • Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies. PMID: 9920160. Transfusion. 1999 Jan;39:6–10
  • Hannon JL. Management of blood donors and blood donations from individuals found to have a positive direct antiglobulin test. Transfus Med Rev. 2012;26(2):142–152.
  • Berentsen S. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia. Front Immunol. 2020;11:590.
  • Donath J, Landsteiner K. Ueber Paroxysmale Hämoglobinurie. Münchener medizinische Wochenschrift. 1904;36:1590–1593.
  • Kilty M, Ipe TS. Donath-Landsteiner test. Immunohematology. 2019;35(1):3–6.
  • Dittmar K, Procter JL, Cipolone K, et al. Comparison of DATs using traditional tube agglutination to gel column and affinity column procedures. Transfusion. 2001;41(10):1258–1262.
  • Novaretti MC, Jens E, Pagliarini T, et al. Comparison of conventional tube test technique and gel microcolumn assay for direct antiglobulin test: a large study. J Clin Lab Anal. 2004;18(5):255–258.
  • Chaudhary R, Das SS, Gupta R, et al. Application of flow cytometry in detection of red-cell-bound IgG in Coombs-negative AIHA. Hematology. 2006;11(4):295–300.
  • Fayek MH, Saad AA, Eissa DG, et al. Role of gel test and flow cytometry in diagnosis of Coombs’ negative autoimmune haemolytic anaemia. Int J Lab Hematol. 2012;34(3):311–319.
  • Kamesaki T, Oyamada T, Omine M, et al. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia. Am J Hematol. 2009;84(2):98–101.
  • Fabijańska-Mitek J, Pogłod R, Adamowicz-Salach A, et al. Quantitation of red cell-bound IgG by an enzyme-linked antiglobulin test in the patients with warm-type autoimmune haemolytic anaemia. Clin Lab Haematol. 2006;28(4):241–244.
  • Bartolmäs T, Salama A. A dual antiglobulin test for the detection of weak or nonagglutinating immunoglobulin M warm autoantibodies. Transfusion. 2010;50(5):1131–1134.
  • Arndt PA, Leger RM, Garratty G. Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies. Transfusion. 2009;49(2):235–242.
  • Barcellini W, Clerici G, Montesano R, et al. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol. 2000;111(2):452–460. DOI:10.1046/j.1365-2141.2000.02380.x
  • Barcellini W, Revelli N, Imperiali FG, et al. Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity. Int J Hematol. 2010;91(5):762–769. DOI:10.1007/s12185-010-0578-9
  • Barcellini W, Montesano R, Clerici G, et al. In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. Am J Hematol. 2002;71(3):177–183. DOI:10.1002/ajh.10210
  • Barcellini W, Iurlo A, Radice T, et al. Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns. Leuk Res. 2013;37(11):1509–1515. DOI:10.1016/j.leukres.2013.09.001
  • Barcellini W, Fattizzo B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers. 2015;2015:635670.
  • Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021;137(10):1283–1294.
  • Van De Loosdrecht AA, Hendriks DW, Blom NR, et al. Excessive apoptosis of bone marrow erythroblasts in a patient with autoimmune haemolytic anaemia with reticulocytopenia. Br J Haematol. 2000;108(2):313–315.
  • Hauke G, Fauser AA, Weber S, et al. Reticulocytopenia in severe autoimmune hemolytic anemia (AIHA) of the warm antibody type. Blut. 1983;46(6):321–327.
  • Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014;124(19):2930–2936. DOI:10.1182/blood-2014-06-583021
  • Barcellini W, Zaninoni A, Fattizzo B, et al. Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. Am J Hematol. 2018;93(9):E243–246. DOI:10.1002/ajh.25212
  • Fattizzo B, Giannotta J, Zaninoni A, et al. Small paroxysmal nocturnal hemoglobinuria clones in autoimmune hemolytic anemia: clinical implications and different cytokine patterns in positive and negative patients. Front Immunol. 2020;11:1006.
  • Hill QA, Stamps R, Massey E, et al. British society for haematology guidelines. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017;177(2):208–220.
  • Fattizzo B, Giannotta JA, Serpenti F, et al. Difficult cases of autoimmune hemolytic anemia: a challenge for the internal medicine specialist. J Clin Med. 2020;9(12):3858.
  • Berentsen S. How I treat cold agglutinin disease. Blood. 2021;137(10):1295–1303.
  • Audia S, Bach B, Samson M, et al. Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS ONE. 2018;13(11):e0207218. DOI:10.1371/journal.pone.0207218
  • Broome CM, Cunningham JM, Mullins M, et al. Increased risk of thrombotic events in cold agglutinin disease: a 10-year retrospective analysis. Res Pract Thromb Haemost. 2020;4(4):628–635. DOI:10.1002/rth2.12333
  • Berentsen S, Barcellini W, D’Sa S, et al. Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood. 2020;136(4):480–488. DOI:10.1182/blood.2020005674
  • Fattizzo B, Bortolotti M, Giannotta JA, et al. Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia. J Thromb Haemost. 2022;20(8):1852–1858. DOI:10.1111/jth.15757
  • Giannotta JA, Fattizzo B, Cavallaro F, et al. Infectious complications in autoimmune hemolytic anemia. J Clin Med. 2021;10(1):164. DOI:10.3390/jcm10010164
  • Fattizzo B, Michel M, Giannotta JA, et al. Evans syndrome in adults: an observational multicenter study. Blood Adv. 2021;5(24):5468–5478. DOI:10.1182/bloodadvances.2021005610
  • Fattizzo B, Michel M, Zaninoni A, et al. Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study. Haematologica. 2021;106(2):622–625. DOI:10.3324/haematol.2020.250522
  • Salama A, Hartnack D, Lindemann HW, et al. The effect of erythropoiesis-stimulating agents in patients with therapy-refractory autoimmune hemolytic anemia. Transfus Med Hemother. 2014;41(6):462–468.
  • Barcellini W, Fattizzo B. The changing landscape of autoimmune hemolytic anemia. Front Immunol. 2020;11:946.
  • Fattizzo B, Zaninoni A, Gianelli U, et al. Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia. Am J Hematol. 2018 Aug;93(4):E88–91.
  • Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes. Am J Hematol. 2017;92(3):E26–9. DOI:10.1002/ajh.24618
  • Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229–1253. DOI:10.1182/blood.2022015851
  • Randen U, Trøen G, Tierens A, et al. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica. 2014;99(3):497–504. DOI:10.3324/haematol.2013.091702
  • Małecka A, Trøen G, Tierens A, et al. Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease. Br J Haematol. 2018;183(5):838–842. DOI:10.1111/bjh.15063
  • Fattizzo B, Barcellini W. Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects. Front Oncol. 2020;9:1435.